Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC.ACHV · Entity 5072 | Director | May 31, 2022 | June 01, 2022 |
| Tracon Pharmaceuticals, Inc.TCON · Entity 91134 | Director | April 19, 2023 | April 21, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACHIEVE LIFE SCIENCES, INC.
Report date May 31, 2022 · Filed June 01, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.90 · Expires 2032-05-31 | Direct | 4,400 |
Reported balance
After 2022-05-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-05-31 · Grant · Acquired 4,400 · Balance 4,400 F1: The options vest 100% on the earlier of May 31, 2023 or the date immediately prior to the Issuer's next annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest 100% on the earlier of May 31, 2023 or the date immediately prior to the Issuer's next annual meeting of stockholders.
Tracon Pharmaceuticals, Inc.
Report date April 19, 2023 · Filed April 21, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.82 · Expires 2033-04-18 | Direct | 18,000 |
Reported balance
After 2023-04-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-04-19 · Grant · Acquired 18,000 · Balance 18,000 F1: The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders, subject to the optionee's Continuous Service (as defined in the Company's 2015 Equity Incentive Plan (the "Plan")) and accelerated on the closing of a Change of Control (as defined in the Plan). |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders, subject to the optionee's Continuous Service (as defined in the Company's 2015 Equity Incentive Plan (the "Plan")) and accelerated on the closing of a Change of Control (as defined in the Plan).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 19, 2023 Filed Apr 21, 2023 20:44 UTC | Tracon Pharmaceuticals, Inc. TCON · Entity 91134 | GrantDirector Stock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $1.82 | $0.00 |
DisclosureSEC source: 0001209191-23-025285 · doc4.xml · derivative · entry 1 MATTINGLY MARTIN A · CIK 0001265782 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2033-04-18 F1 · derivative.exercise_date: The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders, subject to the optionee's Continuous Service (as defined in the Company's 2015 Equity Incentive Plan (the "Plan")) and accelerated on the closing of a Change of Control (as defined in the Plan). Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 21:23 UTC | Tracon Pharmaceuticals, Inc. TCON · Entity 91134 | GrantDirector Stock Option (Right to Buy) · Derivative | 15,750 | $0.00 Strike: $1.30 | $0.00 |
DisclosureSEC source: 0001209191-22-037675 · doc4.xml · derivative · entry 1 MATTINGLY MARTIN A · CIK 0001265782 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,750 Underlying: Common Stock · 15,750 shares Expires 2032-06-13 F1 · derivative.exercise_date: The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders, subject to the optionee's Continuous Service (as defined in the Company's 2015 Equity Incentive Plan (the "Plan")) and accelerated on the closing of a Change of Control (as defined in the Plan). Read SEC document |
| May 31, 2022 Filed Jun 1, 2022 20:08 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 4,400 | $0.00 Strike: $6.90 | $0.00 |
DisclosureSEC source: 0001209191-22-033133 · doc4.xml · derivative · entry 1 MATTINGLY MARTIN A · CIK 0001265782 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,400 Underlying: Common Stock · 4,400 shares Expires 2032-05-31 F1 · derivative.exercise_date: The options vest 100% on the earlier of May 31, 2023 or the date immediately prior to the Issuer's next annual meeting of stockholders. Read SEC document |
| June 10, 2021 Filed Jun 24, 2021 19:01 UTC | Tracon Pharmaceuticals, Inc. TCON · Entity 91134 | GrantDirector Stock Option (Right to Buy) · Derivative | 10,500 | $0.00 Strike: $6.55 | $0.00 |
DisclosureSEC source: 0001209191-21-043142 · doc4.xml · derivative · entry 1 MATTINGLY MARTIN A · CIK 0001265782 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,500 Underlying: Common Stock · 10,500 shares Expires 2031-06-09 F1 · derivative.exercise_date: The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders. Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:22 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 3,750 | $0.00 Strike: $9.90 | $0.00 |
DisclosureSEC source: 0001209191-21-032335 · doc4.xml · derivative · entry 1 MATTINGLY MARTIN A · CIK 0001265782 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires 2031-05-11 F1 · derivative.exercise_date: The options vest 100% on the earlier of May 11, 2022 or the date immediately prior to the Issuer's next annual meeting of stockholders. Read SEC document |
| June 10, 2020 Filed Jun 16, 2020 17:31 UTC | Tracon Pharmaceuticals, Inc. TCON · Entity 91134 | GrantDirector Stock Option (Right to Buy) · Derivative | 4,500 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001209191-20-037024 · doc4.xml · derivative · entry 1 MATTINGLY MARTIN A · CIK 0001265782 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500 Underlying: Common Stock · 4,500 shares Expires 2030-06-09 F1 · derivative.exercise_date: The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders. Read SEC document |
| May 12, 2020 Filed May 14, 2020 20:12 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 22,000 | $0.00 Strike: $0.43 | $0.00 |
DisclosureSEC source: 0001209191-20-029165 · doc4.xml · derivative · entry 1 MATTINGLY MARTIN A · CIK 0001265782 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2030-05-12 F1 · derivative.exercise_date: The options vest 100% on the earlier of May 12, 2021 or the date immediately prior to the Issuer's next annual meeting of stockholders. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 12:34 UTC | Tracon Pharmaceuticals, Inc. TCON · Entity 91134 | GrantDirector Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $0.64 | $0.00 |
DisclosureSEC source: 0001209191-19-037343 · doc4.xml · derivative · entry 1 MATTINGLY MARTIN A · CIK 0001265782 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2029-06-12 F1 · derivative.exercise_date: The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders. Read SEC document |
| May 14, 2019 Filed May 15, 2019 20:44 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $4.02 | $0.00 |
DisclosureSEC source: 0001209191-19-030045 · doc4.xml · derivative · entry 1 MATTINGLY MARTIN A · CIK 0001265782 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 7,000 shares Expires 2029-05-14 F1 · derivative.exercise_date: The options vest 100% on the earlier of May 14, 2020 or the date immediately prior to the Issuer's next annual meeting of stockholders. Read SEC document |
| September 20, 2018 Filed Sep 21, 2018 20:47 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $2.56 | $0.00 |
DisclosureSEC source: 0001209191-18-051906 · doc4.xml · derivative · entry 1 MATTINGLY MARTIN A · CIK 0001265782 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2028-09-20 F1 · derivative.exercise_date: The options vest in monthly installments over one year commencing one month from September 20 2018. Read SEC document |
| June 13, 2018 Filed Jun 13, 2018 20:04 UTC | Tracon Pharmaceuticals, Inc. TCON · Entity 91134 | GrantDirector Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001209191-18-037612 · doc4.xml · derivative · entry 1 MATTINGLY MARTIN A · CIK 0001265782 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2028-06-12 F1 · derivative.exercise_date: The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:54 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $4.57 | $0.00 |
DisclosureSEC source: 0001209191-17-047588 · doc4.xml · derivative · entry 2 MATTINGLY MARTIN A · CIK 0001265782 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2027-08-01 Read SEC document |
| August 01, 2017 Filed Sep 12, 2017 19:01 UTC Amendment | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $2.89 | $0.00 |
DisclosureSEC source: 0001209191-17-052382 · doc4a.xml · derivative · entry 1 MATTINGLY MARTIN A · CIK 0001265782 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2027-08-01 F1 · derivative.exercise_price: This amended Form 4 is filed to correct the exercise price to reflect that the grant was effective as of the issuer's first open trading window after approval of the grant. All other terms remain the same. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 20:48 UTC | Tracon Pharmaceuticals, Inc. TCON · Entity 91134 | GrantDirector Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001209191-17-040266 · doc4.xml · derivative · entry 1 MATTINGLY MARTIN A · CIK 0001265782 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-14 F1 · derivative.exercise_date: The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.